Home > Companies > Myralis Pharma

Myralis Pharma

Total dedication to life Innovative and modern in the pharmaceutical sector, the goal to be achieved is in line with what we propose to our clients and partners: always look forward. The reason? The health of thousands of people. Pioneering, Excellence and Technology in our Brands of Success. With a highly qualified Research and Development team, we are able to work together with our physicians, launching pioneering brands in the market. Our growth gives us the certainty of the path and enthusiasm to move forward. That is why we have evolved at a fast and constant pace, delivering innovative medicines not only for our own line but also for a network of partners.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

3rd European Congress on Pharmaceutical Science And Research

Pharmaceutics and Advanced Drug Delivery Systems

16th World Drug Delivery Summit

Pharma2022

World Drug Safety Congress Europe

19th Annual Pharma Data Congress

Related News

SMALL MOLECULES LEAD IN RECENT NEW DRUG APPROVALS

DCAT Value Chain Insights | February 05, 2020

Small molecules still lead over biologics in recent drug approvals, accounting for nearly three-fourths of drug approvals over the past several years, but will small molecules' dominance continue? DCAT Value Chain Insights takes an inside look. One measure to evaluate the role of small molecules versus biologics is to look how they have fared in recent approvals of new molecular entities (NMEs) by the US Food and Drug Administration’s Center for Drug Evaluation and Research. Between 20...

PHARMA TECH

TETRATE-NAMED-2021-COOL-VENDOR-IN-CLOUD-COMPUTING-BY-GARTNER

Omnicell | November 11, 2021

Omnicell, Inc. a leading provider of medication management solutions and adherence tools for health systems and pharmacies, and Fresenius Kabi, a global health care company that specializes in medicines and technologies for infusion, transfusion, and clinical nutrition, are collaborating to provide U.S. hospitals and health systems with innovative new pharmacy technology designed to support safety and efficiency in dispensing of controlled substances in patient care areas. Managin...

PHARMA TECH

PHANES THERAPEUTICS REVEALS SPECPAIR™ TECHNOLOGY PLATFORM THAT ENHANCES MANUFACTURABILITY OF BISPECIFIC ANTIBODIES

Phanes Therapeutics | September 13, 2021

Phanes Therapeutics, Inc., an emerging leader in innovative drug discovery research and development in immuno-oncology announced today that it has developed a proprietary technology platform, SPECpair™, which enables the use of the conventional monoclonal antibody (mAb) manufacturing process in the production of native IgG-like bispecific antibodies. This is the third technology platform Phanes has developed since the launch of the PACbody™ and ATACCbody™ platforms, which are d...

LEVINE LEICHTMAN CAPITAL PARTNERS PORTFOLIO COMPANY CAPSA HEALTHCARE ACQUIRES ROBOPHARMA

Capsa Healthcare | August 14, 2020

Capsa Healthcare ("Capsa"), a portfolio company of Levine Leichtman Capital Partners ("LLCP"), announced today that it has acquired NewRobo Development B.V. and subsidiaries (collectively, "RoboPharma"). RoboPharma, based in Waalwijk, Netherlands, creates and implements pharmacy automation solutions for some of the largest pharmacies in Europe. Capsa is a leading provider of innovative, highly engineered workflow products that increase efficiency and reduce costs, e...